ChemicalBook--->CAS DataBase List--->691868-19-6

691868-19-6

691868-19-6 Structure

691868-19-6 Structure
IdentificationBack Directory
[Name]

Iso-Fludelone
[CAS]

691868-19-6
[Synonyms]

Iso-Fludelone
(4S,7R,8S,9S,10E,13E,16S)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(E)-1-(5-methyl-1,2-oxazol-3-yl)prop-1-en-2-yl]-13-(trifluoromethyl)-1-oxacyclohexadeca-10,13-diene-2,6-dione
Oxacyclohexadeca-10,13-diene-2,6-dione, 4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1E)-1-methyl-2-(5-methyl-3-isoxazolyl)ethenyl]-13-(trifluoromethyl)-, (4S,7R,8S,9S,10E,13E,16S)-
[Molecular Formula]

C27H36F3NO6
[MOL File]

691868-19-6.mol
[Molecular Weight]

527.57
Chemical PropertiesBack Directory
[Boiling point ]

634.9±55.0 °C(Predicted)
[density ]

1.164±0.06 g/cm3(Predicted)
[pka]

13.42±0.70(Predicted)
Hazard InformationBack Directory
[Uses]

Isofludelone (KOS-1803) is a potential microtubule stabilizer for the treatment of solid tumors. Isofludelone has antitumor activity[1].
[References]

[1] Christner SM, et al. Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS. J Pharm Biomed Anal. 2014 Nov;100:199-204. DOI:10.1016/j.jpba.2014.08.007
691868-19-6 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:691868-19-6 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.